The results of TRELAS will contribute to the question whether cTnT elevation in ischemic stroke is associated with myocardial LV dysfunction, and whether TTC is a relevant differential diagnosis in this clinical situation. The gene discussed is TNNT2; the disease is ischemic stroke.